Kcentra 1,000 unit vials
Ended Awarded Last action
- Contract number
- SPE2DR26FHCY6
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,593
Award facts
- Contract value 100% obligated
- $20,592.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $20,592.96 to DMS Pharmaceutical Group Inc. for 1,000 unit vials of Kcentra on December 9, 2025, with an ultimate completion date of December 31, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected under a firm fixed-price contract structure with no set-aside designation. The company will deliver the product to Park Ridge, Illinois, leveraging its established position as a critical supplier within the federal pharmaceutical supply chain.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V initiative, designated as contract SPE2DR. The parent contract, valued at $499.999 billion with a completion date of December 31, 2036, positions DMS Pharmaceutical Group as one of multiple regional prime vendor contractors within the $30.3 billion PPV-G GEN V acquisition strategy. The IDC authorizes the Defense Logistics Agency to issue delivery orders for comprehensive pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables to support recurring medical supply needs of Department of Defense military healthcare facilities worldwide. Kcentra, a prothrombin complex concentrate used for urgent reversal of vitamin K antagonist anticoagulation, represents a critical specialty pharmaceutical product supporting emergency medical care capabilities across the military healthcare system.
Quick answers
Who was awarded contract SPE2DR26FHCY6?
SPE2DR26FHCY6 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 9, 2025.
How much is contract SPE2DR26FHCY6 worth?
The government has obligated $20,593 on SPE2DR26FHCY6.
Is contract SPE2DR26FHCY6 an order under another contract?
Yes. SPE2DR26FHCY6 is a delivery order under SPE2DR25D9207, an indefinite delivery contract.
Was contract SPE2DR26FHCY6 competed?
The extent of competition for SPE2DR26FHCY6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award